Efficacy of Letermovir in Preventing Cytomegalovirus (CMV) Infection in Lung Transplant Recipients vs. Valganciclovir.

Clinical trial NCT06057194 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06057194
Sponsor: Maimónides Biomedical Research Institute of Córdoba
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Infections, Cytomegalovirus

Start date: 2023-10-01
Primary completion: 2027-04-01
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.